Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue, Brown | 11 | 2024 | 100 | 5.750 |
Why?
|
Proto-Oncogene Proteins c-akt | 17 | 2022 | 185 | 3.550 |
Why?
|
Mechanistic Target of Rapamycin Complex 2 | 9 | 2020 | 17 | 3.190 |
Why?
|
Adipocytes | 14 | 2022 | 252 | 3.010 |
Why?
|
TOR Serine-Threonine Kinases | 19 | 2022 | 115 | 2.930 |
Why?
|
Adipose Tissue, White | 10 | 2022 | 82 | 2.740 |
Why?
|
Adipocytes, Brown | 8 | 2023 | 45 | 2.460 |
Why?
|
Adipogenesis | 9 | 2019 | 71 | 2.360 |
Why?
|
Thermogenesis | 8 | 2024 | 108 | 2.210 |
Why?
|
Lipogenesis | 7 | 2020 | 65 | 2.200 |
Why?
|
Obesity | 11 | 2023 | 1189 | 2.140 |
Why?
|
ATP Citrate (pro-S)-Lyase | 3 | 2024 | 17 | 1.790 |
Why?
|
Glutamine | 2 | 2024 | 47 | 1.760 |
Why?
|
Multiprotein Complexes | 10 | 2016 | 150 | 1.670 |
Why?
|
Protein Kinases | 10 | 2009 | 139 | 1.660 |
Why?
|
Insulin | 9 | 2022 | 687 | 1.560 |
Why?
|
Rapamycin-Insensitive Companion of mTOR Protein | 9 | 2022 | 11 | 1.560 |
Why?
|
Signal Transduction | 26 | 2022 | 2890 | 1.370 |
Why?
|
Transcription Factors | 10 | 2017 | 1456 | 1.310 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2022 | 675 | 1.310 |
Why?
|
Animals | 48 | 2024 | 19607 | 1.240 |
Why?
|
Adipose Tissue | 6 | 2024 | 283 | 1.180 |
Why?
|
Carrier Proteins | 8 | 2020 | 710 | 1.180 |
Why?
|
Subcutaneous Fat | 2 | 2020 | 50 | 1.170 |
Why?
|
Mice | 32 | 2024 | 10253 | 1.150 |
Why?
|
Glucose | 7 | 2023 | 444 | 1.130 |
Why?
|
Myogenic Regulatory Factor 5 | 4 | 2014 | 16 | 1.110 |
Why?
|
Neoplasms | 5 | 2023 | 1234 | 1.060 |
Why?
|
Insulin Resistance | 7 | 2019 | 403 | 1.000 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 9 | 2017 | 53 | 0.980 |
Why?
|
Cell Lineage | 8 | 2019 | 250 | 0.960 |
Why?
|
Nuclear Proteins | 5 | 2019 | 759 | 0.940 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2019 | 34 | 0.910 |
Why?
|
PTEN Phosphohydrolase | 4 | 2012 | 83 | 0.900 |
Why?
|
Metabolic Diseases | 1 | 2024 | 51 | 0.890 |
Why?
|
Adipocytes, White | 2 | 2015 | 27 | 0.890 |
Why?
|
Lipid Metabolism | 4 | 2020 | 200 | 0.890 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2012 | 168 | 0.850 |
Why?
|
Acetyl Coenzyme A | 1 | 2023 | 23 | 0.840 |
Why?
|
Stress, Physiological | 1 | 2024 | 185 | 0.830 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2022 | 5 | 0.820 |
Why?
|
Protein Interaction Maps | 1 | 2022 | 33 | 0.820 |
Why?
|
Cold Temperature | 2 | 2021 | 51 | 0.760 |
Why?
|
Isotope Labeling | 1 | 2021 | 68 | 0.760 |
Why?
|
Energy Metabolism | 5 | 2022 | 348 | 0.710 |
Why?
|
Forkhead Box Protein O1 | 2 | 2019 | 16 | 0.690 |
Why?
|
Cell Growth Processes | 2 | 2012 | 36 | 0.690 |
Why?
|
Fatty Acids | 4 | 2024 | 194 | 0.680 |
Why?
|
Second Messenger Systems | 1 | 2019 | 26 | 0.680 |
Why?
|
Cell Division | 5 | 2006 | 442 | 0.670 |
Why?
|
Sirtuins | 1 | 2019 | 26 | 0.660 |
Why?
|
Protein Kinase Inhibitors | 2 | 2012 | 169 | 0.660 |
Why?
|
Lipolysis | 1 | 2019 | 47 | 0.650 |
Why?
|
Muscle Development | 2 | 2019 | 53 | 0.640 |
Why?
|
Sirtuin 1 | 1 | 2018 | 23 | 0.630 |
Why?
|
Oncogenes | 1 | 2019 | 68 | 0.620 |
Why?
|
Gastrointestinal Transit | 1 | 2018 | 6 | 0.620 |
Why?
|
Phosphorylation | 10 | 2022 | 861 | 0.610 |
Why?
|
Sirolimus | 6 | 2012 | 73 | 0.600 |
Why?
|
Gene Knockout Techniques | 3 | 2020 | 89 | 0.580 |
Why?
|
Trans-Activators | 2 | 2012 | 295 | 0.580 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 3186 | 0.570 |
Why?
|
Humans | 34 | 2024 | 59302 | 0.570 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 326 | 0.570 |
Why?
|
Lipodystrophy | 1 | 2017 | 11 | 0.560 |
Why?
|
Cell Cycle Proteins | 4 | 2004 | 375 | 0.530 |
Why?
|
Protein Subunits | 1 | 2016 | 164 | 0.500 |
Why?
|
Cell Differentiation | 5 | 2019 | 1295 | 0.500 |
Why?
|
Homologous Recombination | 1 | 2015 | 25 | 0.490 |
Why?
|
rab1 GTP-Binding Proteins | 1 | 2014 | 6 | 0.480 |
Why?
|
Integrases | 1 | 2015 | 36 | 0.480 |
Why?
|
Liver | 3 | 2016 | 784 | 0.470 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 254 | 0.430 |
Why?
|
Citric Acid Cycle | 2 | 2024 | 25 | 0.430 |
Why?
|
Schizosaccharomyces pombe Proteins | 3 | 2004 | 74 | 0.420 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 324 | 0.410 |
Why?
|
Schizosaccharomyces | 4 | 2004 | 106 | 0.410 |
Why?
|
Drosophila Proteins | 5 | 2011 | 681 | 0.390 |
Why?
|
Mice, Knockout | 7 | 2019 | 1987 | 0.390 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 253 | 0.390 |
Why?
|
Cell Survival | 1 | 2012 | 553 | 0.360 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2001 | 57 | 0.360 |
Why?
|
Autophagy | 1 | 2012 | 205 | 0.350 |
Why?
|
Fatty Acid Synthases | 2 | 2020 | 22 | 0.330 |
Why?
|
Muscle, Skeletal | 4 | 2023 | 673 | 0.320 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2006 | 31 | 0.320 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 47 | 0.320 |
Why?
|
Saccharomyces cerevisiae Proteins | 3 | 2004 | 418 | 0.310 |
Why?
|
Proteins | 9 | 2012 | 742 | 0.310 |
Why?
|
Protein Kinase C-alpha | 2 | 2006 | 16 | 0.290 |
Why?
|
HEK293 Cells | 2 | 2020 | 577 | 0.290 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 118 | 0.290 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 8 | 0.280 |
Why?
|
Drosophila | 3 | 2006 | 419 | 0.270 |
Why?
|
Genes, Developmental | 1 | 2006 | 5 | 0.270 |
Why?
|
Male | 13 | 2023 | 27481 | 0.260 |
Why?
|
Gene Expression Regulation | 4 | 2017 | 1537 | 0.260 |
Why?
|
Metabolic Networks and Pathways | 2 | 2023 | 72 | 0.250 |
Why?
|
Models, Biological | 5 | 2016 | 1139 | 0.250 |
Why?
|
Spindle Apparatus | 2 | 2002 | 123 | 0.240 |
Why?
|
Gene Expression | 2 | 2020 | 808 | 0.230 |
Why?
|
PPAR gamma | 3 | 2020 | 71 | 0.230 |
Why?
|
Glycolysis | 2 | 2021 | 54 | 0.230 |
Why?
|
Disease Models, Animal | 4 | 2023 | 2061 | 0.220 |
Why?
|
Mitosis | 2 | 2002 | 208 | 0.220 |
Why?
|
Mice, Transgenic | 2 | 2019 | 1221 | 0.220 |
Why?
|
Body Fat Distribution | 2 | 2013 | 11 | 0.210 |
Why?
|
Genes, cdc | 1 | 2002 | 14 | 0.210 |
Why?
|
Adipokines | 1 | 2022 | 28 | 0.210 |
Why?
|
Genomics | 2 | 2024 | 314 | 0.210 |
Why?
|
RNA Interference | 6 | 2011 | 589 | 0.200 |
Why?
|
Protein Interaction Mapping | 1 | 2022 | 71 | 0.200 |
Why?
|
DNA Damage | 1 | 2024 | 277 | 0.200 |
Why?
|
Phosphatidylglycerols | 1 | 2021 | 10 | 0.190 |
Why?
|
Metabolomics | 1 | 2022 | 50 | 0.190 |
Why?
|
Metabolome | 1 | 2021 | 23 | 0.190 |
Why?
|
Cells, Cultured | 5 | 2014 | 2103 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 192 | 0.190 |
Why?
|
Luminescent Proteins | 3 | 2012 | 129 | 0.190 |
Why?
|
Gene Targeting | 2 | 2015 | 82 | 0.190 |
Why?
|
Protein Binding | 5 | 2009 | 1550 | 0.180 |
Why?
|
Diet, High-Fat | 3 | 2019 | 159 | 0.180 |
Why?
|
Homeostasis | 3 | 2019 | 340 | 0.180 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 303 | 0.180 |
Why?
|
Amino Acids | 1 | 2021 | 140 | 0.180 |
Why?
|
Adult | 4 | 2023 | 15729 | 0.180 |
Why?
|
Acetate-CoA Ligase | 1 | 2020 | 1 | 0.170 |
Why?
|
Transcriptome | 2 | 2021 | 324 | 0.170 |
Why?
|
Female | 9 | 2019 | 30799 | 0.170 |
Why?
|
Response Elements | 1 | 2020 | 42 | 0.170 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 697 | 0.170 |
Why?
|
Glucose Transporter Type 4 | 1 | 2020 | 56 | 0.170 |
Why?
|
HeLa Cells | 2 | 2019 | 527 | 0.160 |
Why?
|
Neural Crest | 1 | 2019 | 29 | 0.160 |
Why?
|
Proteome | 1 | 2020 | 135 | 0.160 |
Why?
|
Protein Methyltransferases | 1 | 2019 | 14 | 0.160 |
Why?
|
Neural Stem Cells | 1 | 2019 | 43 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2019 | 32 | 0.160 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 76 | 0.160 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 13 | 0.160 |
Why?
|
Methylation | 1 | 2019 | 126 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 193 | 0.160 |
Why?
|
Neurogenesis | 1 | 2019 | 59 | 0.160 |
Why?
|
Stromal Cells | 1 | 2018 | 65 | 0.150 |
Why?
|
Proteomics | 1 | 2020 | 252 | 0.150 |
Why?
|
Carcinogenesis | 1 | 2019 | 115 | 0.150 |
Why?
|
Uncoupling Protein 1 | 1 | 2017 | 47 | 0.150 |
Why?
|
Gene Deletion | 2 | 2016 | 298 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2013 | 416 | 0.140 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 350 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 195 | 0.140 |
Why?
|
Histones | 1 | 2020 | 463 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 178 | 0.130 |
Why?
|
Mutation | 4 | 2006 | 2427 | 0.130 |
Why?
|
Tuberculosis | 1 | 2019 | 261 | 0.130 |
Why?
|
Protein Structure, Tertiary | 4 | 2015 | 663 | 0.130 |
Why?
|
Gene Editing | 1 | 2020 | 289 | 0.130 |
Why?
|
Organ Specificity | 1 | 2016 | 178 | 0.130 |
Why?
|
Flow Cytometry | 2 | 2012 | 671 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 630 | 0.120 |
Why?
|
Inflammation | 2 | 2019 | 1101 | 0.120 |
Why?
|
Cytoskeleton | 2 | 2006 | 140 | 0.120 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2011 | 22 | 0.120 |
Why?
|
Up-Regulation | 2 | 2006 | 363 | 0.120 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2014 | 15 | 0.120 |
Why?
|
MyoD Protein | 1 | 2014 | 43 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2014 | 47 | 0.110 |
Why?
|
Stem Cells | 1 | 2016 | 257 | 0.110 |
Why?
|
Cell Proliferation | 3 | 2013 | 944 | 0.110 |
Why?
|
Th2 Cells | 1 | 2013 | 98 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 315 | 0.110 |
Why?
|
Diet | 1 | 2017 | 635 | 0.110 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2012 | 6 | 0.100 |
Why?
|
Lipomatosis | 1 | 2012 | 8 | 0.100 |
Why?
|
Histological Techniques | 1 | 2012 | 18 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 439 | 0.100 |
Why?
|
Leukemia | 1 | 2012 | 53 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2012 | 123 | 0.100 |
Why?
|
Muscle Cells | 1 | 2011 | 27 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 192 | 0.100 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2011 | 6 | 0.100 |
Why?
|
Sarcoma | 1 | 2011 | 34 | 0.100 |
Why?
|
Cell Separation | 1 | 2011 | 149 | 0.090 |
Why?
|
Ribosomal Protein S6 | 1 | 2011 | 1 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 525 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2017 | 843 | 0.090 |
Why?
|
Longevity | 1 | 2012 | 111 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 740 | 0.090 |
Why?
|
Drug Discovery | 1 | 2012 | 91 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 643 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 288 | 0.090 |
Why?
|
Regulatory-Associated Protein of mTOR | 4 | 2013 | 7 | 0.080 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2009 | 2 | 0.080 |
Why?
|
Everolimus | 1 | 2009 | 17 | 0.080 |
Why?
|
Microarray Analysis | 2 | 2011 | 58 | 0.080 |
Why?
|
Cell Line | 3 | 2015 | 2014 | 0.080 |
Why?
|
Green Fluorescent Proteins | 2 | 2001 | 353 | 0.080 |
Why?
|
T-Lymphocytes | 1 | 2013 | 963 | 0.080 |
Why?
|
Mice, Obese | 2 | 2019 | 79 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 3 | 2011 | 219 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 158 | 0.080 |
Why?
|
Prostate | 1 | 2009 | 54 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2011 | 694 | 0.080 |
Why?
|
Mice, Nude | 1 | 2009 | 259 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 222 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2017 | 5063 | 0.070 |
Why?
|
Phenotype | 2 | 2009 | 1155 | 0.070 |
Why?
|
Young Adult | 1 | 2017 | 4318 | 0.070 |
Why?
|
3T3 Cells | 2 | 2018 | 108 | 0.070 |
Why?
|
Drosophila melanogaster | 3 | 2011 | 480 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 293 | 0.070 |
Why?
|
Fibroblasts | 1 | 2009 | 367 | 0.070 |
Why?
|
Forkhead Box Protein O3 | 1 | 2006 | 8 | 0.070 |
Why?
|
Fetal Viability | 1 | 2006 | 3 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 880 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2006 | 26 | 0.070 |
Why?
|
Fetal Development | 1 | 2006 | 17 | 0.070 |
Why?
|
Middle Aged | 3 | 2019 | 16232 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 41 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2012 | 749 | 0.070 |
Why?
|
Cell Enlargement | 1 | 2006 | 9 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2009 | 375 | 0.070 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 161 | 0.060 |
Why?
|
Precipitin Tests | 2 | 2004 | 79 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 73 | 0.060 |
Why?
|
Down-Regulation | 1 | 2006 | 306 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 182 | 0.060 |
Why?
|
Immunoblotting | 2 | 2004 | 190 | 0.060 |
Why?
|
Blotting, Western | 2 | 2011 | 595 | 0.060 |
Why?
|
Cell Cycle | 3 | 2013 | 379 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 847 | 0.060 |
Why?
|
Ribosomes | 1 | 2006 | 153 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2004 | 1582 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2004 | 1977 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 1370 | 0.050 |
Why?
|
Adrenergic Agents | 1 | 2022 | 16 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2004 | 216 | 0.050 |
Why?
|
Cell Death | 1 | 2024 | 267 | 0.050 |
Why?
|
Plant Cells | 1 | 2002 | 11 | 0.050 |
Why?
|
Actomyosin | 1 | 2002 | 20 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2002 | 111 | 0.050 |
Why?
|
Yeasts | 1 | 2002 | 51 | 0.050 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2002 | 42 | 0.050 |
Why?
|
Carbon Isotopes | 1 | 2022 | 18 | 0.050 |
Why?
|
Aged | 1 | 2017 | 13285 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 55 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 299 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2001 | 21 | 0.050 |
Why?
|
Microtubules | 1 | 2002 | 211 | 0.050 |
Why?
|
RNA | 1 | 2004 | 404 | 0.050 |
Why?
|
Catalysis | 1 | 2001 | 154 | 0.050 |
Why?
|
Catalytic Domain | 1 | 2001 | 184 | 0.040 |
Why?
|
Plasmids | 1 | 2001 | 282 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2022 | 285 | 0.040 |
Why?
|
Gene Ontology | 1 | 2020 | 37 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 376 | 0.040 |
Why?
|
Temperature | 1 | 2001 | 300 | 0.040 |
Why?
|
Tubulin | 1 | 2000 | 74 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 119 | 0.040 |
Why?
|
Mutagenesis | 1 | 2000 | 129 | 0.040 |
Why?
|
Alleles | 1 | 2001 | 425 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 397 | 0.040 |
Why?
|
Neural Tube | 1 | 2019 | 11 | 0.040 |
Why?
|
Twist-Related Protein 1 | 1 | 2019 | 12 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 357 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 502 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 135 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2000 | 385 | 0.040 |
Why?
|
Acetylation | 1 | 2019 | 111 | 0.040 |
Why?
|
Carnitine O-Acetyltransferase | 1 | 2018 | 1 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 292 | 0.040 |
Why?
|
Neuroglia | 1 | 2019 | 79 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 83 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 304 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 123 | 0.040 |
Why?
|
Apoptosis | 1 | 2024 | 1038 | 0.040 |
Why?
|
Lentivirus | 1 | 2018 | 62 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 1128 | 0.040 |
Why?
|
Cytosol | 1 | 2018 | 169 | 0.040 |
Why?
|
Hypoxia | 1 | 2018 | 107 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 851 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2016 | 23 | 0.030 |
Why?
|
3T3-L1 Cells | 1 | 2017 | 83 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 96 | 0.030 |
Why?
|
Mitochondria | 1 | 2020 | 333 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 421 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 64 | 0.030 |
Why?
|
Ubiquitination | 1 | 2016 | 106 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 193 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 102 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 13 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 21 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2015 | 70 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 383 | 0.030 |
Why?
|
CRISPR-Cas Systems | 1 | 2018 | 325 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2005 | 353 | 0.030 |
Why?
|
Neurons | 1 | 2019 | 858 | 0.030 |
Why?
|
Sequence Alignment | 2 | 2004 | 290 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 14 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 50 | 0.030 |
Why?
|
Time Factors | 1 | 2000 | 3567 | 0.030 |
Why?
|
Gluconeogenesis | 1 | 2012 | 15 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 58 | 0.020 |
Why?
|
Muscle Neoplasms | 1 | 2011 | 7 | 0.020 |
Why?
|
Aurothioglucose | 1 | 2011 | 2 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 5 | 0.020 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 1 | 0.020 |
Why?
|
Biomarkers | 1 | 2017 | 1205 | 0.020 |
Why?
|
ras Proteins | 1 | 2011 | 78 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2011 | 84 | 0.020 |
Why?
|
Survival Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 275 | 0.020 |
Why?
|
Chromatin | 1 | 2015 | 594 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 118 | 0.020 |
Why?
|
Triglycerides | 1 | 2011 | 242 | 0.020 |
Why?
|
Cytokines | 1 | 2013 | 906 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 139 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2011 | 846 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 330 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2011 | 213 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 484 | 0.020 |
Why?
|
Genome | 1 | 2011 | 253 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2011 | 454 | 0.020 |
Why?
|
Rats | 1 | 2011 | 1907 | 0.020 |
Why?
|
Models, Genetic | 1 | 2006 | 253 | 0.020 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 4 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 116 | 0.020 |
Why?
|
Serine | 1 | 2005 | 83 | 0.010 |
Why?
|
Gene Components | 1 | 2004 | 5 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 810 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 73 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2004 | 171 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2004 | 98 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 291 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2004 | 160 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 248 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 133 | 0.010 |
Why?
|
Software | 1 | 2006 | 367 | 0.010 |
Why?
|
Equipment Design | 1 | 2004 | 314 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 636 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 396 | 0.010 |
Why?
|
Actins | 1 | 2004 | 260 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 673 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 1546 | 0.010 |
Why?
|